Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV was delisted on the 26th of May, 2020.
30 hedge funds and large institutions have $46M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 5 closing their positions.
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
31% more capital invested
Capital invested by funds: $35M → $46M (+$11M)
11% more funds holding
Funds holding: 27 → 30 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
83% less call options, than puts
Call options by funds: $242K | Put options by funds: $1.42M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.73M |
| 2 |
VOAM
Vertex One Asset Management
Vancouver,
British Columbia, Canada
|
+$3.24M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
+$2.41M |
| 4 |
BC
Broadfin Capital
New York
|
+$1.61M |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$651K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIG
Fortress Investment Group
New York
|
-$12.1M |
| 2 |
ACM
Alistair Capital Management
Dallas,
Texas
|
-$2.85M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.61M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$318K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$257K |
CORV Hedge Fund Activity: Q1 2014 in Review
30 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q1 2014, worth a combined $46M — up 31% from $35M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CORV positions and 5 closed out — a net gain of 3 holders — while 11 added to existing stakes and 7 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $9.73M. The largest seller was Fortress Investment Group, cutting an estimated $12.1M.
- 30 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q1 2014, up from 27 in Q4 2013.
- Funds reported $46M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q1 2014, up 31% quarter-over-quarter.
- 8 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q1 2014 and 5 closed out, a net change of +3 holders.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q1 2014 was Fidelity Investments, an estimated $9.73M added.
- The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q1 2014 was Fortress Investment Group, an estimated $12.1M sold.
Based on aggregated 13F filings for Q1 2014.